Table 2:
Distribution by treatment group of variables included in the previously-described predictor model* for single-dose misoprostol success of early pregnancy loss management
| Full cohort | Misoprostol alone | Mifepristone pretreatment | p-value | |
|---|---|---|---|---|
| Active bleeding | 0.65 | |||
| No | 288 (77) | 117 (79) | 111 (75) | |
| Yes | 34 (11) | 17 (11) | 17 (11) | |
| Not Assessed | 35 (12) | 15 (10) | 20 (14) | |
| Diagnosis | 0.67 | |||
| Embryonic/fetal demise | 220 (74) | 112 (75) | 108 (73) | |
| Anembryonic gestation | 77 (26) | 37 (25) | 40 (27) | |
| Parity | 0.19 | |||
| 0 | 114 (38) | 51 (34) | 63 (43) | |
| 1 | 89 (30) | 44 (30) | 45 (30) | |
| 2+ | 94 (32) | 54 (36) | 40 (27) | |
| Gestational age | 0.75 | |||
| <7 Weeks | 107 (36) | 27 (37) | 80 (36) | |
| 7–8 6/7 Weeks | 144 (48) | 33 (45) | 111 (50) | |
| 9–12 6/7 Weeks | 46 (15) | 13 (18) | 33 (15) | |
| Site | 0.99 | |||
| University of Pennsylvania | 160 (54) | 80 (54) | 80 (54) | |
| University of California, Davis | 76 (26) | 38 (26) | 38 (26) | |
| Albert Einstein College of Medicine | 61 (21) | 31 (21) | 30 (20) |
Data are presented as n (%).
*
from Creinin MD, Huang X, Westhoff C, Barnhart K, Gilles JM, Zhang J, et al. Factors related to successful misoprostol treatment for early pregnancy failure. Obstet Gynecol. 2006;107 (4):901–7.